|
Information For:
|
Revision BulletinMercaptopurine Tablets
In accordance with the Rules and Procedures of the 2005-2010 Council of Experts, the Biopharmaceutics Expert Committee has revised the Mercaptopurine Tablets monograph by revising the tolerances in Dissolution Test 2 to be in accordance with the U.S. Food and Drug Administration. The Mercaptopurine Tablets Revision Bulletin supersedes the currently official monograph and will be incorporated into the First Supplement to the USP 33-NF 28 Reissue. Should you have any questions, please contact Margareth Marques, Ph.D., (301–816–8106 or . Download the Mercaptopurine Tablets Revision Bulletin What's New
![]() USP recalled USP 33-NF 28 on Jan. 8, 2010. A reissue product will be available in April 2010.
PF 36(2), March-April 2010: IRAs and Errata (03/01/10) February Revision Bulletins (02/26/10) Protamine Monographs: Notice of Intent to Revise (02/26/10) New Draft Pending Standard for the month of February (02/26/10) PF 36(2), March-April 2010: Highlights (02/22/10) Calculation Tool for the Performance Verification Test (PVT) of Dissolution Assemblies (02/22/10) Performance of Equipment to Test Dissolution of Medications Further Assured (02/09/10) New Official Text (01/29/10) Related Resources |
||||||||||||||||||||||||||||
Copyright © 2010 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||